Home › Funds › Oasis Management Co Ltd. › TBPH
Oasis Management Co Ltd. position in TBPH
THERAVANCE BIOPHARMA INC
Oasis Management Co Ltd. reported holding 583,490 shares of TBPH (THERAVANCE BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 0.55% of its reported portfolio and ranking #17 among its reported holdings. Oasis Management Co Ltd. has disclosed TBPH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Oasis Management Co Ltd.'s TBPH position evolved
Oasis Management Co Ltd. first disclosed a stake in TBPH in Q3 2023 at 953,254 shares (US$8.2M). The position peaked in Q3 2025 at 1,118,935 shares, worth US$16.3M. Across 12 filings, Oasis Management Co Ltd. increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 583,490 shares valued at US$9.9M. Notable position changes include a 35% trim in Q4 2025.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 953.25K | $8.23M | New |
| Q4 2023 | 1.01M | $11.32M | Add |
| Q1 2024 | 1.16M | $10.39M | Add |
| Q2 2024 | 1.16M | $9.82M | Hold |
| Q3 2024 | 1.12M | $8.99M | Reduce |
| Q4 2024 | 1.12M | $10.50M | Hold |
| Q1 2025 | 1.12M | $9.99M | Hold |
| Q2 2025 | 1.12M | $12.34M | Hold |
| Q3 2025 | 1.12M | $16.34M | Hold |
| Q4 2025 | 727.16K | $13.61M | Reduce |
| Q1 2026 | 583.49K | $9.47M | Reduce |
| Q2 2026 | 583.49K | $9.92M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TBPH and 13F data
TBPH (THERAVANCE BIOPHARMA INC) is a company whose sector is not yet classified in our data. 31 other funds we track also report a position in TBPH — the largest reported positions include Madison Avenue Partners, LP (US$156.6M), Weiss Asset Management LP (US$126.8M), Newtyn Management, LLC (US$58.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TBPH
- Madison Avenue Partners, LP 9.21M sh · $156.61M · Q2 2026
- Weiss Asset Management LP 7.46M sh · $126.77M · Q2 2026
- Newtyn Management, LLC 3.43M sh · $58.38M · Q2 2026
- Irenic Capital Management LP 2.76M sh · $46.94M · Q2 2026
More on Oasis Management Co Ltd.
FAQ
How long has Oasis Management Co Ltd. held TBPH?
Oasis Management Co Ltd. has disclosed TBPH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Oasis Management Co Ltd.'s current position in TBPH?
As of Q2 2026, Oasis Management Co Ltd. holds 583.49K shares of TBPH (THERAVANCE BIOPHARMA INC), valued at $9.92M, representing 0.55% of its reported portfolio and ranking #17.
Has Oasis Management Co Ltd. been buying or selling TBPH?
In the latest 13F filing (Q2 2026), Oasis Management Co Ltd. held unchanged its position in TBPH. The position peaked in Q3 2025 at 1.12M shares.
Which other funds hold TBPH?
Other major institutional holders of TBPH include Madison Avenue Partners, LP, Weiss Asset Management LP, Newtyn Management, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.